HC1119

DRUG2 trials

Sponsors

Hinova Pharmaceuticals Inc.

Conditions

Metastatic Castration Resistant Prostate Cancer

Phase 1

A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics

CompletedNCT03776968

Hinova Pharmaceuticals Inc.Metastatic Castration Resistant Prostate Cancer

Start: 2017-10-24End: 2018-07-03Updated: 2024-10-23

A Study Evaluating Enzalutamide Pharmacokinetics and Pharmacodynamics, and Related Changes After Drug Switch

CompletedNCT03778047

Hinova Pharmaceuticals Inc.Metastatic Castration Resistant Prostate Cancer

Start: 2018-02-07End: 2019-08-28Updated: 2020-11-03